Cargando…
Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression
BACKGROUND: Many neurodegenerative diseases are associated with protein misfolding/aggregation. Treatments mitigating the effects of such common pathological processes, rather than disease-specific symptoms, therefore have general therapeutic potential. RESULTS: Here we report that the anti-epilepti...
Autores principales: | Chen, Xi, McCueF, Hannah V., Wong, Shi Quan, Kashyap, Sudhanva S., Kraemer, Brian C., Barclay, Jeff W., Burgoyne, Robert D., Morgan, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587861/ https://www.ncbi.nlm.nih.gov/pubmed/26419537 http://dx.doi.org/10.1186/s13024-015-0046-3 |
Ejemplares similares
-
Erratum to: Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression
por: Chen, Xi, et al.
Publicado: (2015) -
Neuronal functions of FOXO/DAF-16
por: Kim, Sun Y., et al.
Publicado: (2017) -
Using Caenorhabditis elegans to fight human neurodegenerative diseases
por: Chen, Xi, et al.
Publicado: (2013) -
DAF-16/FOXO Transcription Factor in Aging and Longevity
por: Sun, Xiaojuan, et al.
Publicado: (2017) -
Cell-Nonautonomous Effects of dFOXO/DAF-16 in Aging
por: Alic, Nazif, et al.
Publicado: (2014)